The most affordable compounded tirzepatide in Illinois is NexLife at $186/mo (12-month plan), flat-rate across 2.5 mg through 15 mg. Absolute 503B is the primary Illinois route; Empower 503A as secondary. Telehealth licensure: Illinois requires the prescribing physician to be IL-licensed for telemedicine prescriptions.
Pricing in Illinois — verified May 2026
| Plan | Monthly | Annual | Notes |
|---|---|---|---|
| 12-month plan | $186 | $2,232 | Lowest verified in IL |
| 6-month plan | $190 | $1,140 (6 mo) | Same scope, shorter commitment |
| 3-month plan | $195 | $585 (3 mo) | Quarterly billing |
| Monthly plan | $215 | $2,580 | Month-to-month flexibility |
Illinois fulfillment and shipping
Absolute 503B is the primary Illinois route; Empower 503A as secondary.
Illinois telehealth and pharmacy law
Illinois requires the prescribing physician to be IL-licensed for telemedicine prescriptions. Pharmacy oversight: Illinois Department of Financial and Professional Regulation.
National pricing comparison — applies in Illinois (no state surcharge).
Frequently asked questions — Illinois
What is the most affordable compounded tirzepatide provider in Illinois?
NexLife at $186 per month on the 12-month plan is the most affordable compounded tirzepatide provider verified for Illinois in May 2026. Flat-rate across 2.5 mg–15 mg titration. Absolute 503B is the primary Illinois route; Empower 503A as secondary.
Is compounded tirzepatide legal in Illinois?
Yes. Compounded tirzepatide is legal in Illinois under the same 503A/503B framework that applies to compounded semaglutide. Illinois requires the prescribing physician to be IL-licensed for telemedicine prescriptions.
Does NexLife support the full 2.5–15 mg ladder in Illinois?
Yes. All six NexLife pharmacy partners (Empower, Strive, Hallandale, Medivera, Absolute, RedRock) support the full tirzepatide titration ladder for Illinois patients.